Richard Silver, MD, Weill Cornell Medical College, New York, NY, provides an overview of the use of interferons for the treatment of myeloproliferative neoplasms (MPNs), in particular commenting on how MPN disease biology means that interferons are a suitable treatment. This interview took place at the Texas MPN Workshop: Second Annual Workshop and Meeting in 2021.

свернуть